AbbVie vs Abbott (ABBV vs ABT)

AbbVie (ABBV) vs Abbott (ABT) in plain English: P/E, growth, margins, debt and dividend side by side, key differences and which fits each investor profile.

AbbVie (ABBV) and Abbott (ABT) compete in healthcare and pharma. Here are AbbVie and Abbott side by side with their real figures as of November 4, 2026: what sets them apart, which fits each kind of investor and the most common questions, without telling you whether to buy AbbVie or Abbott.

AbbVie vs Abbott: the figures

AbbVie and Abbott figures from Yahoo Finance, the same source the Fintols analysis uses, retrieved on November 4, 2026; N/A means that AbbVie or Abbott figure is not available, and we never estimate it.

3 key differences between AbbVie and Abbott

1. Profitability: for every 100 of sales, AbbVie keeps 15.7 as net profit and Abbott keeps 9.7.
2. Valuation: AbbVie trades at 50.7x its annual earnings and Abbott at 42.9x; the market pays more for each dollar of AbbVie profit, usually because it expects more growth.
3. Volatility: Abbott stock moves more (beta 0.54) than AbbVie (beta 0.19); the higher the beta, the more it amplifies market swings.

AbbVie or Abbott: which fits your profile

• If you want growth: Abbott is growing faster today, so it fits better with investors who put business growth first, usually accepting a higher P/E and a bumpier ride.
• If you want income (dividends): AbbVie pays the higher dividend relative to its price.
• If you prefer caution: AbbVie has less debt relative to its profit, which usually gives more room in a bad year.
• If price is what matters most to you: Abbott trades on the lower P/E; check first whether that is an opportunity or a sign of a business that grows less.

Neither AbbVie nor Abbott wins on everything, and owning both is also an option: spreading money across several companies or an index fund reduces what rides on each one.

How AbbVie and Abbott make money

AbbVie (ABBV)

AbbVie earns its money from branded drugs grouped into therapeutic areas: Immunology, led by Skyrizi, Rinvoq and Humira, is the biggest, followed by Oncology (Imbruvica, Venclexta), Neuroscience (Vraylar, therapeutic Botox) and Aesthetics (cosmetic Botox, Juvederm). The United States is by far its largest market. Full AbbVie analysis.

Abbott (ABT)

Abbott reports four segments: Medical Devices, the largest, including FreeStyle Libre glucose sensors and heart devices; Diagnostics, selling lab analyzers and tests; Nutrition, with Similac, PediaSure and Ensure; and Established Pharmaceuticals, branded generic drugs sold in emerging markets. It operates in the U.S. and internationally. Full Abbott analysis.

Frequently asked questions: AbbVie vs Abbott

Is AbbVie or Abbott the better stock?

Choosing between AbbVie and Abbott depends on what you are looking for. Abbott is growing faster right now, and Abbott trades on the lower P/E. Fintols does not tell you whether to buy AbbVie or Abbott: it shows you the differences so you can decide.

Which pays a higher dividend, AbbVie or Abbott?

As of November 4, 2026, AbbVie yields 2.42% and Abbott yields 2.30%. Also check how much of their profit AbbVie and Abbott pay out: if it is more than they earn, it cannot last.

Which is more expensive, AbbVie or Abbott?

On P/E, AbbVie (50.7x) is more expensive than Abbott (42.9x) as of November 4, 2026. A higher P/E can be justified if earnings grow faster, so compare it with each company's growth in the table.

Can I own both AbbVie and Abbott?

Yes. Many people spread their money across several companies, such as AbbVie and Abbott, or use index funds so they do not depend on just one. If you are starting out, decide how much you want to invest and for how long before buying AbbVie or Abbott.

More comparisons with AbbVie or Abbott

• AbbVie vs Amgen
• AbbVie vs Eli Lilly
• Abbott vs Amgen
• Abbott vs Eli Lilly

More companies like AbbVie and Abbott: healthcare and pharma stocks. Educational content about AbbVie and Abbott, not investment advice.